Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

Inclusion Criteria

• •Patient, male, aged between ≥ 40 and ≤ 75 years
• •Patient with a life expectancy \> 10 years at the time of inclusion.
• •Patient with a therapeutic strategy (prostatectomy or focal HIFU) defined during a PCR.
• •Patient with a diagnosis of localised prostate cancer at favourable intermediate risk
• •Patient able to tolerate general anaesthesia or type IV sedation
• •Patient with normal urinary continence status
• •Patient with satisfactory erectile function allowing penetration:
• •Patient with targeted biopsies and systematic biopsies
• •Patient affiliated to or benefiting from a social security scheme
• •French-speaking patients who do not object to the use of their data.